A Form 4 filed on September 23, 2026 reports changes in beneficial ownership of derivative securities by Michael Berman, a director of InspireMD, Inc. (NASDAQ:NSPR), with transactions dated September 18, 2026.
Key Highlights
- Reporting person: Michael Berman, director of InspireMD, Inc.
- Transaction code J: Four separate warrant transactions were reported, all dated September 18, 2026.
- Series J Warrants: Two Series J Warrants (right to buy Common Stock) at exercise prices of $1.3827 and $0.7674, each involving 30,625 shares, were reported at a price of $0 per derivative security; beneficial ownership following the transactions stands at 30,624 and 30,625 respectively, held indirectly.
- Series K Warrants: Two Series K Warrants (right to buy Common Stock) at exercise prices of $1.3827 and $0.7674, each involving 61,248 shares, were reported at a price of $0 per derivative security; beneficial ownership following the transactions stands at 0 and 61,248 respectively, held indirectly.
- All warrants: The expiration date listed for all four derivative securities is May 15, 2023, with the date exercisable noted as May 15, 2023.
- Indirect ownership: All reported positions are held indirectly, with the nature of indirect beneficial ownership referenced to footnotes citing Exhibit 99.1.
Warrant Transactions Reported by InspireMD Director Michael Berman
According to the Form 4 filed with the SEC on September 23, 2026, Michael Berman, who is identified as a director of InspireMD, Inc. (NASDAQ:NSPR), reported changes in beneficial ownership of derivative securities. The date of earliest transaction is listed as September 21, 2026, and the individual transactions in Table II carry a date of September 18, 2026. The filing was signed by Michael Lawless as Attorney-in-Fact for Michael Berman.
The filing discloses four derivative security positions, all classified as warrants giving the right to buy Common Stock and all carrying transaction code "J." Two involve Series J Warrants: one with an exercise price of $1.3827 covering 30,625 shares, resulting in remaining beneficial ownership of 30,624 shares indirectly held; and one with an exercise price of $0.7674 covering 30,625 shares, with 30,625 remaining indirectly held. Both were acquired at a reported derivative security price of $0. The filing references Exhibit 99.1 and specific notes for further detail on each transaction.
Two Series K Warrants are also disclosed under transaction code "J." The first, at an exercise price of $1.3827, involved 61,248 shares and resulted in zero remaining beneficial ownership. The second, at $0.7674, involved 61,248 shares and resulted in 61,248 shares remaining indirectly held. Both are also reported at a derivative security price of $0. All four warrants list May 15, 2023 as both the date exercisable and the expiration date. No Table I non-derivative security transactions were reported.
What Was Disclosed
The filing reports four derivative security transactions by InspireMD director Michael Berman involving Series J and Series K Warrants, all transacted at a reported price of $0, with resulting indirect beneficial ownership positions varying across the four warrant classes.



Please wait processing your request...